UPDATE 2-Strong drug sales keep Shire on track | Reuters
Links shared publicly online about this topic.
- 0total visits
UPDATE 2-Strong drug sales keep Shire on track | Reuters
* Q3 non-GAAP earnings per ADS $1.28 vs forecast $1.30* Q3 revenue $1.09 billion vs forecast $1.07 billion* Shire says on track to hit raised analyst 2011 forecasts* Shares down 1.3 pctBy Paul San
View full resource at reuters.com
Tags: ADHD, ADHD Medication, Drug, Pharma, Shire
Most Recently Shared on October 28, 2011 at 1:30 pm By:
Back-to-school sales of Shire's ADHD meds help boost Q3 sales by 24% http://t.co/T5Q5ewOz #pharma
Advertisement
